Search results
The Bird Flu Outbreak Is Alarming. And the Government Is Stumbling.
Bloomberg· 2 days agoThe Bird Flu Outbreak Is Alarming. The H5N1 crisis at dairy farms shows that public health agencies...
Carmichael and McCray square off in U.S. Senate primary to face Banks in the fall general
South Bend Tribune via Yahoo News· 12 hours agoI will make it a priority to end abusive pricing practices by the pharmaceutical industry and give...
Amneal introduces generic OTC naloxone nasal spray By Investing.com
Investing.com· 3 hours agoAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) has announced the launch of its generic Over the Counter...
Firms learn more from 'knowledge-gap' failures than mere 'slip-ups,' says study
Phys.org· 1 day agoA study co-written by a team of University of Illinois Urbana-Champaign business scholars and...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 3 days agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
The S&P 500 Is Near Its Record High: Here's What Warren Buffett Is Doing
Motley Fool via Yahoo Finance· 2 days agoMoreover, some companies in the pharmaceutical industry have been witnessing increased buying...
Asia And Europe Markets Recover While Crude Oil Slides - Global Markets Today While US Slept -...
Benzinga· 6 days agoIn Australia, the S&P/ASX 200 gained 0.48% to finish at 7,642.10, led by gains in the Metals &...
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and...
Zacks via Yahoo Finance· 1 day agoYou can see all of today's research reports here >>> Shares of Novartis have gained +2.3% over the...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks· 17 hours agoFree Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing ...
Edgewise's sevasemten earns EU orphan drug status By Investing.com
Investing.com· 1 day agoEdgewise Therapeutics, Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle diseases,...